100 related articles for article (PubMed ID: 1977176)
21. Dopamine D1 receptor modulation of pilocarpine-induced convulsions.
Barone P; Parashos SA; Palma V; Marin C; Campanella G; Chase TN
Neuroscience; 1990; 34(1):209-17. PubMed ID: 2139189
[TBL] [Abstract][Full Text] [Related]
22. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
Weathersby RT; Appel JB
Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
[TBL] [Abstract][Full Text] [Related]
23. Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements.
Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M
Eur J Pharmacol; 1994 Jan; 252(1):99-104. PubMed ID: 7908646
[TBL] [Abstract][Full Text] [Related]
24. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin.
Pilip S; Urbańska EM; Swiader M; Włodarczyk D; Kleinrok Z; Czuczwar SJ; Turski WA
Pol J Pharmacol; 2000; 52(4):267-73. PubMed ID: 11345482
[TBL] [Abstract][Full Text] [Related]
25. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors.
Alam AM; Starr MS
Eur J Pharmacol; 1992 Nov; 222(2-3):227-32. PubMed ID: 1451735
[TBL] [Abstract][Full Text] [Related]
26. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
Maeda N; Matsuoka N; Yamaguchi I
Brain Res; 1990 Dec; 537(1-2):163-8. PubMed ID: 1982238
[TBL] [Abstract][Full Text] [Related]
27. Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.
Yurek DM; Hipkens SB
Brain Res; 1994 Mar; 639(2):329-32. PubMed ID: 7911393
[TBL] [Abstract][Full Text] [Related]
28. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
Imperato A; Di Chiara G
Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
[TBL] [Abstract][Full Text] [Related]
29. Effect of dihydroergotoxine on the susceptibility of rats to convulsions produced by different convulsant agents.
Pericić D; Manev H
Psychopharmacology (Berl); 1983; 80(2):171-3. PubMed ID: 6410446
[TBL] [Abstract][Full Text] [Related]
30. Influence of levodopa, apomorphine and 3,4-dihydroxyphenylserine (DOPS) on strychnine-induced seizures in mice.
Wambebe C; Osuide G; Gamaniel K
Gen Pharmacol; 1984; 15(3):243-5. PubMed ID: 6428968
[TBL] [Abstract][Full Text] [Related]
31. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
Deshpande C; Dhir A; Kulkarni SK
Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
[TBL] [Abstract][Full Text] [Related]
32. Seizure promotion by D1 agonists does not correlate with other dopaminergic properties.
Starr MS; Starr BS
J Neural Transm Park Dis Dement Sect; 1993; 6(1):27-34. PubMed ID: 8105796
[TBL] [Abstract][Full Text] [Related]
33. The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
Stewart BR; Jenner P; Marsden CD
Psychopharmacology (Berl); 1988; 96(1):55-62. PubMed ID: 2906443
[TBL] [Abstract][Full Text] [Related]
34. Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.
Swiader M; Gasior M; Wielosz M; Czuczwar SJ
Pol J Pharmacol; 2003; 55(4):649-53. PubMed ID: 14581726
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic stimulation of oxytocin concentrations in the plasma of male and female monkeys by apomorphine and a D2 receptor agonist.
Cameron JL; Pomerantz SM; Layden LM; Amico JA
J Clin Endocrinol Metab; 1992 Sep; 75(3):855-60. PubMed ID: 1355489
[TBL] [Abstract][Full Text] [Related]
36. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
Taylor MD; de Ceballos ML; Jenner P; Marsden CD
Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
[TBL] [Abstract][Full Text] [Related]
37. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of intrathecally administered picrotoxin- and bicuculline-induced convulsions in mice by pipecolic acid or GABA.
Beitz AJ; Larson AA
Eur J Pharmacol; 1985 Aug; 114(2):181-7. PubMed ID: 2995078
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizure in mice.
Satoh H; Nakanishi H; Shirakawa K; Kohjimoto Y; Kuwaki T; Ono T; Shibayama F
Jpn J Pharmacol; 1987 Jan; 43(1):27-32. PubMed ID: 2883332
[TBL] [Abstract][Full Text] [Related]
40. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
Meller E; Hizami R; Kreuter L
Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
